Albuquerque-based company lands patent for novel Alzheimer’s technology

The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in patients to diagnose and treat Alzheimer's.

First Bank extends growth streak with $181M deal for SC’s GrandSouth Bank

My View: The National Labor Relations Board shouldn’t be picking sides

Here’s when D.C.’s flagship Apple store is expected to open

Real Estate Roundup: Mizner Park’s office space fills up

Q&A: Tariffs, labor shortages keep new home prices high, says new MBA director

Like a good food hall? Greater Washington’s scene continues to grow.

Smith & Wollensky ‘optimistic’ about new location as its Easton restaurant will close Jan. 14

Cafe Express closes locations in Dallas, Houston, Austin

Albuquerque-based company lands patent for novel Alzheimer’s technology

Previous Medical Mutual is leaving downtown Cleveland headquarters

Next Business Coalition on Health hits 10th anniversary with 50 members, 1.5 million covered lives

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Bay Harbor Islands apartment complexes sell for $22.5M

Charlotte spot lands on The New York Times list of best restaurants

2022 Best Places to Work: JNBA Financial Advisors earns third BPTW award

Guest viewpoint: Silicon Valley Bank alive and open for business six months after collapse

Icon Entertainment & Hospitality adds Co-CEO amidst portfolio growth

Providence negotiating sale of part of its Renton headquarters campus

MENU

FirstStar Group

More Stories

TD Bank CEO Leo Salom on economy, Ukraine, First Horizon deal and early impressions of Philadelphia